Phase 2 Study To Investigate the Efficacy, Safety And Pharmacokinetics Of Ravidasvir In Combination With Ritonavir-boosted Danoprevir And Ribavirin In Treatment-naive Non-cirrhotic Taiwanese Patients Who Have Chronic Hepatitis C Genotype 1
Phase of Trial: Phase II
Latest Information Update: 06 Jul 2017
At a glance
- Drugs Danoprevir (Primary) ; Ravidasvir (Primary) ; Ribavirin (Primary) ; Ritonavir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms EVEREST
- Sponsors Ascletis
- 29 Jun 2017 Status changed from active, no longer recruiting to completed.
- 18 Jan 2017 New source identified and integrated (ClinicalTrials.gov; NCT03020095).
- 11 Jan 2017 Status changed from recruiting to active, no longer recruiting.